The Valley Desk

NCT01273610 · Interventional trial

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

Overall registry status Active not recruiting

Phase 2

Conditions Breast Neoplasms, Geriatric Health Services, HER2/Neu Positive

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov